Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1985-08-01
1987-05-26
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514 91, 514112, 514120, 514138, 514277, 514617, 514642, 514731, 514765, A61K 31675, A61K 3166, A61K 3105, A61K 31015, A61K 31435, A61K 31165, A61K 3114
Patent
active
046686673
ABSTRACT:
The present invention involves compounds of the class of acylphosphorotriamides and methods for altering the blood plasma lipid content of mammals which comprises systemically administering to mammals an effective but nontoxic amount of a composition comprising such compounds.
REFERENCES:
patent: 4182881 (1980-01-01), Bayless et al.
patent: 4221730 (1980-09-01), Alaimo et al.
patent: 4454126 (1984-06-01), Yamatsu et al.
Kutty, K. M., R. Redheendran & D. Murphy, "Serum Cholinesterase: Function in Lipoprotein Metabolism", Experientia, vol. 33 (1977), pp. 420-422.
Kutty, K. M., R. Jain, S.-N. Huang & K. Kean, "Serum Pseudocholinesterase: High Density Lipoprotein Cholesterol Ratio as an Index of Risk for Cardiovascular Disease", Clinica Chimica Acta, vol. 115 (1981), pp. 55-61.
Jain, R., K. M. Kutty, S.-N. Huang & K. Kean, "Pseudocholinesterase/High-Density Lipoprotein Cholesterol Ratio in Serum of Normal Persons and of Hyperlipoproteinemics", Clinical Chemistry, vol. 29 (1983), pp. 1031-1033.
Cucuianu, M., T. A. Popescu & S. Haragus, "Pseudocholinesterase in Obese and Hyperlipemic Subjects", Clinica Chimica Acta, vol. 22 (1968), pp. 151-155.
Cucuianu, M., T. A. Popescu, A. Opincaru & S. Haragus, "Serum Pseudocholinesterase and Ceruloplasmin in Various Types of Hyperlipoproteinemia", Clinica Chimica Acta, vol. 59 (1975), pp. 19-27.
Cucuianu, M., A. Opincaru & D. Tapalaga, "Similar Behavior of Lecithin: Cholesterol Acyltransferase and Pseudocholinesterase in Liver Disease and Hyperlipoproteinemia", Clinica Chimica Acta, vol. 85 (1978), pp. 73-79.
Cucuianu, M. P., A. Cristea, S. Roman & I. Missits, "Increased Plasma Antithrombin III Level in Hyperlipidemic Subjects", Clinica Chimica Acta, vol. 110 (1981), pp. 147-155.
Ando, M., S. Hirosaki, K. Tamura & T. Taya, "Multiple Regression Analysis of the Cholinesterase Activity with Certain Physiochemical Factors", Environmental Research, vol. 33 (1984), pp. 96-105.
Kutty, K. M., J. D. Jacob, C. J. Hutton, P. J. Davis & S. C. Peterson, "Serum Beta-Lipoproteins: Studies of a Patient and in Guinea Pigs after the Ingestion of Organophosphorus Compounds", Clinical Biochemistry, vol. 8, (1975), pp. 379-383.
Kutty, K. M., "Review: Bilogical Function of Cholinesterase", Clinical Biochemistry, vol. 13 (1980), pp. 239-243.
Bayless Allan V.
Moorehead Thomas J.
Brown Johnnie R.
Graff IV Milton B.
Norwich Eaton Pharmaceuticals, Inc.
Rollins Jr. John W.
Schaeffer Jack D.
LandOfFree
Acylphosphorotriamides useful as lipid-altering agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acylphosphorotriamides useful as lipid-altering agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acylphosphorotriamides useful as lipid-altering agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-703924